https://www.prweb.com/releases/asymmetrex_proposes_its_technology_for_certifying_therapeutic_stem_cell_dose_and_quality_to_support_anticipated_new_fda_policies_for_experimental_stem_cell_treatments/prweb14837660.htm
Asymmetrex Proposes Its Technology for Certifying Therapeutic Stem Cell Dose and Quality To Support...
BOSTON (PRWEB) October 24, 2017 -- The first suggestion for the FDA was given on September 15 in Kansas City, a little more than two weeks after FDA...